Results 161 to 170 of about 6,633 (220)

Automated larval motility assays reveal links between eprinomectin treatment failure and drug resistance in Haemonchus contortus. [PDF]

open access: yesVet Res
Petermann J   +11 more
europepmc   +1 more source

Hybrid-metagenomics reveal off-target effects of albendazole, ivermectin-albendazole and moxidectin-albendazole on the human gut bacteria

open access: yes
Dommann J   +7 more
europepmc   +1 more source

Moxidectin: an oral treatment for human onchocerciasis [PDF]

open access: yesExpert Review of Anti-Infective Therapy, 2020
Moxidectin is a milbemycin endectocide recently approved for the treatment of human onchocerciasis. Onchocerciasis, earmarked for elimination of transmission, is a filarial infection endemic in Africa, Yemen, and the Amazonian focus straddling Venezuela and Brazil.
Philip Milton   +2 more
exaly   +5 more sources
Some of the next articles are maybe not open access.

Related searches:

Moxidectin induces autophagy arrest in colorectal cancer

Medical Oncology, 2022
Colorectal cancer (CRC) is a cancer with a high morbidity and mortality worldwide. Hence, developing new therapeutic drugs for CRC is very important. Moxidectin (MOX) has shown good anti-glioblastoma effect both in vitro and in vivo. This study aimed to elucidate the anti-CRC effect of MOX and its potential mechanism by investigating the influence of ...
Yushan Mao   +5 more
openaire   +2 more sources

Moxidectin and the avermectins: Consanguinity but not identity

open access: yesInternational Journal for Parasitology: Drugs and Drug Resistance, 2012
The avermectins and milbemycins contain a common macrocyclic lactone (ML) ring, but are fermentation products of different organisms. The principal structural difference is that avermectins have sugar groups at C13 of the macrocyclic ring, whereas the milbemycins are protonated at C13.
Roger K Prichard
exaly   +5 more sources

Home - About - Disclaimer - Privacy